Floatz logo

pds0101

Anal Cancer

Weill Medical College of Cornell UniversityPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

45 Active assets in the Anal Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Federation Francophone de Cancerologie Digestive
Phase 3BB
Carboplatin
Dustin Deming
Phase 3BB
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 3BB
Irinotecan
University of Cincinnati
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Federation Francophone de Cancerologie Digestive
Phase 3BB

View all 50 →

Same molecule, other indications

pds0101 is also rated in:

cervical cancerDormant
CCC
Indicative ·
55 / 100
View asset →
HIV infectious diseaseDormant
CCC
Indicative ·
53 / 100
View asset →
HPV CancersDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →